Mark J. Vignola serves as Executive at Terns Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Mark J. Vignola has executed 8 insider transactions totaling $159.4K, demonstrating a bearish approach to their equity position. Their most recent transaction on Sep 10, 2024 involved selling 10,000 shares valued at $110.0K.
Mark J. Vignola currently holds 91,940 shares of Terns Pharmaceuticals, Inc. (TERN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Mark J. Vignola has been a net seller of TERN stock. They have purchased $49.4K and sold $110.0K worth of shares.
Mark J. Vignola's most recent insider trade was on Sep 10, 2024, when they sold 10,000 shares at $11.00 per share.
Get notified when new Form 4 filings are submitted
| $5.36 |
| Planned |
| May 31, 2024 | TERN | $21.3K | Purchase | 4,791 | $4.44 | Discretionary |
| Jan 23, 2024 | TERN | $0 | Award | 68,750 | $N/A | Discretionary |
| Nov 30, 2023 | TERN | $2.8K | Purchase | 743 | $3.78 | Discretionary |
| May 31, 2023 | TERN | $14.1K | Purchase | 9,997 | $1.41 | Discretionary |
| Nov 30, 2022 | TERN | $4 | Purchase | 3 | $1.41 | Discretionary |
| May 31, 2022 | TERN | $11.3K | Purchase | 7,656 | $1.47 | Discretionary |